EXENS Exosens

57.64USD52.55 EUR · EPA+0.48%Mkt Cap: 2.92B USDP/E: 125.12

Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detectio…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.92B USD
Enterprise Value3.15B USD
Revenue (TTM)550.35M USD
Gross Profit243.82M USD
Net Income (TTM)33.67M USD
Revenue/Share10.89 USD
Last Price57.64 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.0K
CountryFR
SectorIndustrials
IndustryAerospace & Defense
ISINFR001400Q9V2
Valuation
P/E (Trailing)125.12
P/E (Forward)21.53
PEG—
EV/EBITDA27.42
EV/Revenue5.73
P/S5.31
P/B5.93
EPS (TTM)0.46 USD
EPS (Forward)2.68 USD
52W Range
43.8737% of range81.16
52W High81.16 USD
52W Low43.87 USD
Profitability
Gross Margin57.98%
Oper. Margin17.39%
EBITDA Margin20.90%
Profit Margin8.01%
ROE6.89%
ROA3.49%
ROIC16.70%
ROCE10.53%
Growth
Revenue Growth15.30%
Earnings Growth-45.10%
Cash Flow & Leverage
Operating CF117.80M USD
CapEx (TTM)—
FCF Margin5.86%
FCF Yield1.10%
Net Debt219.62M USD
Net Debt/EBITDA1.91
Net Debt/FCF6.81
Balance Sheet
Debt/Equity0.04
Current Ratio2.35
Quick Ratio1.32
Book Value/Sh9.71 USD
Cash/Share1.49 USD
Dividends
Fwd Div Rate0.33 USD
Trail. Div Rate0.33 USD
Div. Yield0.58%
5Y Avg Yield—
Payout Ratio76.63%
Ex-Div DateMay 27, 2026
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)76.61 USD
Upside (mean)+32.9%
Target Range69.10 USD – 82.26 USD
69.10+32.9% to mean82.26
# Analysts10
Ownership
Shares Out.50.67M
Float32.83M
Insiders31.25%
Institutions48.57%
Technical
SMA 5062.38 (-7.6%)
SMA 20066.16 (-12.9%)
Beta0.85
S&P 52W Chg12.00%
Avg Vol (30d)76.18K
Avg Vol (10d)93.95K
Technical Indicators
RSI (14)42.0
MACD-1.5490
MACD Signal-1.4831
MACD Hist.-0.0659
BB Upper65.26 USD
BB Middle59.58 USD
BB Lower53.91 USD
BB Width19.04%
ATR (14)2.201 USD
Vol Ratio (20d)0.56x

About Exosens (EPA: EXENS)

›

Exosens (EPA: EXENS) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 2,000 employees.

The shares were at 52.55 EUR on 19 November 2026, up 24.2% over 52 weeks. Its 52-week range is 40.00 EUR to 74.00 EUR: the price is 29.0% below the high and 31.4% above the low.

At a market capitalisation of 2.66B EUR, it trades at 125.1 times trailing earnings and 21.5 times forward earnings. The median trailing P/E of its 19 largest Aerospace & Defense peers is 31.3, a premium of 299% for EXENS. It pays a dividend yielding 0.58% (it pays out 77% of its earnings), against a median of 1.55% among the dividend payers in that peer group.

Exosens reports return on equity of 6.9%, an operating margin of 17.4% and revenue up 15.3% year over year.

Its debt exceeds its cash by 200.24M EUR, a debt-to-equity ratio of 0.04. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 69.85 EUR is 32.9% above the current price. The next earnings report is expected on 22 February 2027.